(RTTNews) - Taro Pharmaceuticals U.S.A., Inc. has recalled one lot of corticosteroid Clobetasol Propionate in the form of ointment for the potential presence of Ralstonia pickettii bacteria, the U.S.
To date, the Company has not received reports of adverse events related to this recall. Taro Pharmaceuticals has issued a voluntary recall of 1 lot of Clobetasol Propionate Ointment USP, 0.05%, 60g ...
Use this medication on the skin only. Do not use it on the face, groin, or underarms unless directed to do so by your doctor. Wash and dry your hands before using. Clean and dry the affected area.
CORAL GABLES, Fla.--(BUSINESS WIRE)--Stiefel Laboratories, Inc., the world's largest independent pharmaceutical company specializing in dermatology, today announced that the U.S. Food and Drug ...
BUENA, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's ...
Dear Doctors: I have been diagnosed with inverse psoriasis in the area of my groin. My dermatologist has prescribed clobetasol propionate ointment to be used twice a day. The skin in that area bleeds ...
Taro Pharmaceuticals U.S.A., Inc. (“Taro” or the “Company”) is voluntarily recalling one (1) lot of Clobetasol Propionate Ointment USP, 0.05% packaged in 60 g tubes, to the consumer level. This recall ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
HYDERABAD, India & PRINCETON, N.J. & MALVERN, Pa.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), through its wholly owned ...
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Apotex for exclusive rights in Mexico for the commercialization of clobetasol propionate ophthalmic ...
A 40-year-old Hispanic man presented for treatment of dermatitis on his elbows and knees that had been evident for 5 years (Figure 1). He also had scaling plaques on his scalp. He had not been treated ...
Dr. Reddy’s Laboratories announced that the Food and Drug Administration (FDA) has approved Impoyz (clobetasol propionate) Cream 0.025%, formerly DFD-06, for the treatment of moderate to severe plaque ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results